News - August 26, 2009

Gates to fund TBC research in Lelystad

Three million dollars will go towards developing new vaccines in efforts to eradicate TBC by 2050.

The Bill & Melinda Gates Foundation has allocated three million dollars to tuberculosis research by ASG researcher Jelle Thole. Thole is coordinator of the Tuberculosis Vaccine Initiative (TBVI), a collaboration between European TBC researchers. The not-for-profit organization plans to use the money from Gates to strengthen its fund-raising and communication activities. The TBVI hopes to obtain two hundred million euros in sponsorship from governments, funds and companies for the development of new vaccines. Tuberculosis kills nearly 1.8 million people per year. The existing vaccine provides inadequate protection to young adults, the group most often infected by the disease. ‘New vaccines are essential for achieving the international aim of a TBC-free world by 2050’, says Jelle Thole. ‘To make it possible to develop these vaccines, more money is urgently needed.’